BIOCHEM INTERNATIONAL INC

BIOCHEM INTERNATIONAL INC, operating within SIC 3845’s Electromedical & Electrotherapeutic Apparatus specialty, manufactures diagnostic and therapeutic devices leveraging bioelectrical stimulation to support hospitals, specialty clinics, and research centers seeking noninvasive treatment alternatives. The firm’s engineering of electrode arrays, control consoles, and related disposables is tailored to providers managing acute musculoskeletal and chronic pain cases while navigating elevated expectations for durability and patient comfort. Sales efforts emphasize regulatory clearance compliance, third-party reimbursement support, and aftermarket service agreements, aligning the product roadmap with clinician demand for interoperability and data traceability. As a public filer with Form 10-Q dated November 1998, the company must keep shareholders apprised of cash-flow sensitivity tied to capital equipment cycles, FDA and international approvals, and reimbursement policy shifts that could tighten acceptance of electrotherapeutic therapies. CIK 312833 marks its disclosure, so consider viewing live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025